<Disease><Name>G(M1)-GANGLIOSIDOSIS, TYPE III. CHRONIC/ADULT TYPE</Name><Synonym>GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III, OR ADULT TYPE</Synonym><OMIM><Number>230650</Number><URL>http://omim.org/entry/230650</URL></OMIM><Orphanet><Number>354</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=354</URL></Orphanet><Protein><Number>Beta galactosidase</Number><URL>http://www.uniprot.org/uniprot/P16278</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>3p22.3</Gene><ICD>E75.1</ICD><Summary>rare ;autosomal recessive;- infantile form Type I&#160;&#160; ;- late infantile/juvenile form Type II;- adult/chronic form Type III</Summary><Symptoms><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2124</id><symptom>corneal deposits</symptom><category>EYES</category></symtomp><symtomp><id>2164</id><symptom>dysarthria</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2227</id><symptom>dysmorphism / dysmorphic features</symptom><category>HEAD</category></symtomp><symtomp><id>1946</id><symptom>dystonia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2456</id><symptom>grimacing</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1915</id><symptom>onset, adulthood / adoulthood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3311</id><symptom>Parkinsonism</symptom><category>NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>890</id><name>beta-Galactosidase</name><specimen>fibroblasts</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>891</id><name>beta-Galactosidase</name><specimen>leucocytes</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>4503</id><title>The GM1 and GM2 Gangliosidoses: Natural History and Progress toward Therapy</title><author>Regier DS,</author><journal>Pediatr Endocrinol Rev Suppl</journal><year>2016</year><book /><volume>13</volume><number>1</number><pages>663-673</pages><co_aut>et al.</co_aut></literature><literature><id>4502</id><title>GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects</title><author>Brunetti-Pierri N,</author><journal>Mol Genet Metab</journal><year>2008</year><book /><volume>94</volume><number>4</number><pages>391-396</pages><co_aut>Scaglia F</co_aut></literature><literature><id>2457</id><title>Dystonia and parkinsonism in GM1 type 3 gangliosidosis</title><author>Roze E</author><journal>Mov Disord</journal><year>2005</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>154</id><title>&#223;-Galactosidase deficiency (&#223;-galactosidosis): GM1 Gangliosidosis and Morquio B disease</title><author>Suzuki Y</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>2</volume><number>90</number><pages>2785-2823</pages><co_aut>Sakuraba H, Oshima A</co_aut></literature><literature><id>250</id><title>Type 3 GM1 gangliosidosis: characteristic MRI findings correlated with dystonia</title><author>Uyama E</author><journal>Acta Neurol Scand</journal><year>1992</year><book /><volume>86</volume><number>6</number><pages>609-615</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>